COVID-19: Vaccines and Therapeutics
The COVID-19 virus can be especially dangerous for women during pregnancy.
A virtual learning program helps people get 鈥渢he right care, when they need it, close to home.
Pregnant women around the country faced uncertainty upon the arrival of COVID-19.
The Centers for Disease Control and Prevention today released updated guidance for clinicians treating COVID-19 in patients who received the Pfizer COVID-19 antiviral pill Paxlovid.
Pfizer鈥檚 COVID-19 vaccine booster for children under age 5 was 80.3% effective and well tolerated in a clinical trial.
The FDA Tuesday authorized a single booster dose for children in this age group.
The U.S. Postal Service has delivered about 350 million free at-home tests to households since January. On December 15, 2022, the Biden Administration announced its COVID-鈦19 Winter Preparedness Plan. As part of this plan, free COVID-19 tests are once again available through www.COVIDTests.gov.
FDA today authorized a single booster dose for children 5-11 who completed the Pfizer vaccine primary series at least five months before.
FDA yesterday approved using baricitinib to treat COVID-19 in certain hospitalized adults, and warned not to use a Skippack Medical Lab test.
FDA issues updates on a COVID-19 monoclonal antibody and antiviral pill, and certain Fresenius Medical Care hemodialysis machines.